DEA Reschedules Medical Marijuana to Schedule III: What DEA Registrants Need to Know

Learn how to take advantage of DEA registration, unlock 280E tax relief, open the door to international export, and position your medical cannabis business for the federal era before the June 27 deadline.

After years of operating under one of the most punishing tax regimes in American business, medical cannabis operators finally have a window to change that. With marijuana rescheduled to Schedule III, the DEA has opened an expedited registration pathway that unlocks 280E tax relief, improved margins, access to SAFER banking options, and a credible path to global medical cannabis export markets

But this window is narrow.Expedited DEA registration applications close on June 27, and operators in states like Oklahoma face penalties if they fail to register in time. In California, the Department of Cannabis Control has proposed emergency rules that let operators split their adult-use and medical licenses to take advantage of rescheduling. Another opportunity with a narrow runway.

Join Dr. Sherry Boodram, Founder and CEO of CannDelta, for a FREE online masterclass on Monday, June 1 at 3:00 PM EST. If you operate (or plan to operate) in the U.S. medical cannabis market, this is the session that will tell you exactly what to do next, what it costs, what to file, and how to move fast enough to capture the opportunity.

Stick around for a live, interactive Q&A session. Bring your questions and get answers from the team that has helped launch over 300 cannabis businesses across the U.S., Canada, and overseas.

Reserve Your Spot Today!

Webinar Starts In.....

Days
Hours
Minutes
Seconds

What You'll Learn

This masterclass is a deep dive into what DEA rescheduling actually means for your business: the financial upside, the operational implications, and the exact steps to take advantage of the expedited registration window before it closes.

  • Why Schedule III Changes Everything: How rescheduling unlocks 280E tax relief, restores your ability to deduct standard business expenses, and what that means for margins and cashflow.
  • The June 27 Deadline: A clear look at the expedited DEA registration window: who qualifies, why fast-track applications matter, and what happens if you miss the window.
  • Inside the DEA Application: Application fees, required documents, supporting materials, and realistic timelines, so you know exactly what you’re walking into before you start.
  • The Oklahoma Mandate: Why Oklahoma medical operators must register with the federal DEA inside this window or face penalties, and what your compliance team should be doing right now.
  • The California Workaround: Inside the Department of Cannabis Control’s proposed emergency rules: how splitting adult-use and medical licenses at the same premises can unlock 280E benefits under federal rescheduling.
  • Global Export Opportunity: How DEA registration positions your business to participate in international medical cannabis export markets, and why early movers will set the standard.
  • SAFER Banking & Capital Access: What rescheduling and DEA registration mean for your banking relationships, lending options, and the institutional capital that has stayed on the sidelines.
  • How CannDelta Can Help: A walkthrough of how our team supports operators end-to-end through the DEA registration process, from documentation strategy to submission.

Meet the Expert

Dr. Sherry Boodram

CEO and Founder, CannDelta

Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., a leading scientific and regulatory consulting firm. Dr. Boodram holds a Ph.D. in chemistry from York University, a Hon. B.Sc. In Biological Chemistry from the University of Toronto, a certificate in Cannabis law and Regulation from Osgoode Hall Law School of York University, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College. Sherry is highly regarded in the cannabis industry for her expertise in compliance and licensing, guiding numerous companies over regulatory hurdles and ensuring successful business launches and operations. Sherry was integral in international policy development, giving her the tools cannabis businesses need when looking to expand into emerging markets.

Frequently Asked Questions

Who should attend this webinar?
This session is built for U.S. medical cannabis operators of every size (cultivators, manufacturers, processors, and dispensaries) who want to understand DEA registration under Schedule III. It is especially urgent for operators in Oklahoma, who face a registration mandate, and California, where new emergency rules are reshaping how adult-use and medical licenses interact. Dual-use operators in states that permit both medical and recreational activity will also find this session essential.

Yes. There is no cost to attend. Register, show up, and bring your questions.

June 27 is the close of the DEA’s expedited registration window for medical cannabis operators following the move to Schedule III. Applications submitted after that date will not be processed on the fast-track schedule, meaning longer timelines and a slower path to the 280E, banking, and export benefits that come with registration.

We will walk through application fees, required documents, and supporting materials in detail during the session. The short answer is that the documentation is substantial, and the operators who are submitting successfully are the ones who started preparing the moment rescheduling was announced. Come to the session for the full breakdown.

Oklahoma officials have made clear that medical cannabis businesses must register with the federal DEA within the available window or face punishment. We will cover what that registration looks like for Oklahoma operators specifically, the timeline you should be working against, and the compliance steps to take this week.

The California Department of Cannabis Control has proposed emergency rules that allow operators to split adult-use and medical licenses into two separate entities at the same premises: effectively a workaround that lets businesses access 280E tax deductions on the medical side under federal rescheduling. We will walk through what the rule says, what it does not say yet, and how to think about restructuring your operation to take advantage.

Yes, registered attendees will receive a recording after the live session. That said, the Q&A is the most valuable part, so we strongly recommend joining live if you can.

Yes. CannDelta supports operators through every step of the DEA registration process: documentation, compliance positioning, application submission, and ongoing federal alignment. During the webinar we will explain exactly how that engagement works, and how to start a conversation with our team.

Register Below

The expedited window closes on June 27. Don’t lose your spot in the queue. Reserve your seat today and join Dr. Sherry Boodram for a free, no-fluff session on what DEA rescheduling means for your business, and what to do next.